These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 12589173)

  • 1. Anaemia as a risk factor for the progression of chronic kidney disease.
    Deicher R; Hörl WH
    Curr Opin Nephrol Hypertens; 2003 Mar; 12(2):139-43. PubMed ID: 12589173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anemia and cardiovascular and kidney disease.
    Jurkovitz C; Abramson J; McClellan WM
    Curr Opin Nephrol Hypertens; 2006 Mar; 15(2):117-22. PubMed ID: 16481876
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anemia and heart failure in chronic kidney disease.
    Locatelli F; Pozzoni P; Del Vecchio L
    Semin Nephrol; 2005 Nov; 25(6):392-6. PubMed ID: 16298261
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Anaemia, cardiovascular disease and kidney disease: integrating new knowledge in 2002.
    Stevens LA; Levin A
    Curr Opin Nephrol Hypertens; 2003 Mar; 12(2):133-8. PubMed ID: 12589172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Renal malfunction and cardiovascular diseases].
    Koivuviita N; Tertti R; Metsarinne K
    Duodecim; 2006; 122(2):237-42. PubMed ID: 16509074
    [No Abstract]   [Full Text] [Related]  

  • 6. Detection and evaluation of chronic kidney disease.
    Snyder S; Pendergraph B
    Am Fam Physician; 2005 Nov; 72(9):1723-32. PubMed ID: 16300034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chronic kidney disease, heart failure and anemia.
    Virani SA; Khosla A; Levin A
    Can J Cardiol; 2008 Jul; 24 Suppl B(Suppl B):22B-4B. PubMed ID: 18629385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Uremic toxicity and anemia.
    Bonomini M; Sirolli V
    J Nephrol; 2003; 16(1):21-8. PubMed ID: 12649531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Quality of life, fatigue, and activity in Australians with chronic kidney disease: a longitudinal study.
    Bonner A; Caltabiano M; Berlund L
    Nurs Health Sci; 2013 Sep; 15(3):360-7. PubMed ID: 23480135
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Erythropoietin in heart failure.
    Silverberg DS; Wexler D; Blum M; Iaina A; Sheps D; Keren G; Schwartz D
    Semin Nephrol; 2005 Nov; 25(6):397-403. PubMed ID: 16298262
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlates of habitual physical activity in chronic haemodialysis patients.
    Zamojska S; Szklarek M; Niewodniczy M; Nowicki M
    Nephrol Dial Transplant; 2006 May; 21(5):1323-7. PubMed ID: 16421165
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recombinant human erythropoietin for chronic renal failure anaemia in pre-dialysis patients.
    Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Pennington S; Vale L; Wallace S; MacLeod A
    Cochrane Database Syst Rev; 2001; (4):CD003266. PubMed ID: 11687180
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of the therapeutic effects of epoetin zeta and epoetin alpha in the correction of renal anaemia.
    Krivoshiev S; Todorov VV; Manitius J; Czekalski S; Scigalla P; Koytchev R;
    Curr Med Res Opin; 2008 May; 24(5):1407-15. PubMed ID: 18394266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anaemia in end-stage renal disease: pathophysiological considerations.
    Eckardt KU
    Nephrol Dial Transplant; 2001; 16 Suppl 7():2-8. PubMed ID: 11590249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Incidence of chronic kidney disease in India.
    Dash SC; Agarwal SK
    Nephrol Dial Transplant; 2006 Jan; 21(1):232-3. PubMed ID: 16221717
    [No Abstract]   [Full Text] [Related]  

  • 16. Frequency of administration of recombinant human erythropoietin for anaemia of end-stage renal disease in dialysis patients.
    Cody J; Daly C; Campbell M; Donaldson C; Grant A; Khan I; Vale L; Wallace S; MacLeod A
    Cochrane Database Syst Rev; 2002; (4):CD003895. PubMed ID: 12519614
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A prospective multicentre study of the role of anaemia as a risk factor in haemodialysis patients: the MAR Study.
    Portolés J; López-Gómez JM; Aljama P
    Nephrol Dial Transplant; 2007 Feb; 22(2):500-7. PubMed ID: 17023492
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical presentation of renal failure in the aged: chronic renal failure.
    Jassal SV
    Clin Geriatr Med; 2009 Aug; 25(3):359-72. PubMed ID: 19765486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chronic kidney disease: the new silent killer.
    Kopyt NP
    J Am Osteopath Assoc; 2006 Mar; 106(3):133-6. PubMed ID: 16585380
    [No Abstract]   [Full Text] [Related]  

  • 20. [Frequency of anaemia and indications for treatment with epoetin in chronic renal failure at the pre-dialysis stage].
    Jungers PY; Nguyen-Khoa T; Joly D; Choukroun G; Massy ZA; Jungers P
    Presse Med; 2003 Feb; 32(5):212-6. PubMed ID: 12610461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.